SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,274 | -8.5% | 136,318 | +39.1% | 0.00% | – |
| Q2 2023 | $111,726 | -24.0% | 98,006 | 0.0% | 0.00% | – |
| Q1 2023 | $147,009 | +100591.1% | 98,006 | 0.0% | 0.00% | – |
| Q4 2022 | $146 | -99.9% | 98,006 | +6.6% | 0.00% | – |
| Q3 2022 | $142,000 | -31.7% | 91,895 | 0.0% | 0.00% | – |
| Q2 2022 | $208,000 | -64.7% | 91,895 | -64.1% | 0.00% | – |
| Q1 2022 | $590,000 | -60.3% | 255,828 | -0.3% | 0.00% | – |
| Q4 2021 | $1,487,000 | -48.4% | 256,518 | -6.4% | 0.00% | – |
| Q3 2021 | $2,882,000 | +108.2% | 273,978 | +93.2% | 0.00% | – |
| Q2 2021 | $1,384,000 | -18.8% | 141,809 | +20.8% | 0.00% | – |
| Q1 2021 | $1,705,000 | – | 117,406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 100,000 | $580,000 | 0.02% |
| Virtu Financial LLC | 15,980 | $93,000 | 0.01% |
| Jump Financial, LLC | 11,800 | $68,000 | 0.00% |
| Investment Research & Advisory Group, Inc. | 1,400 | $4,000 | 0.00% |
| Cubist Systematic Strategies, LLC | 12,804 | $74,000 | 0.00% |
| UBS Group AG | 22,402 | $130,000 | 0.00% |
| RHUMBLINE ADVISERS | 18,894 | $110,000 | 0.00% |
| Ellevest, Inc. | 18 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 28,771 | $167,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 11,105 | $64,000 | 0.00% |